| Financial Year |
March 31 2023 |
| Monetary Funds |
1,478,731,117.17 |
| Held-for-trading Financial Assets |
20,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
481,395,401.93 |
| Advances to Suppliers |
290,685,397.81 |
| Other Receivables |
186,671,580.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
421,219,496.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,357,472.48 |
| Other Current Assets |
85,055,926.78 |
| Total Current Assets |
2,967,498,639.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
289,849.15 |
| Long-term Equity Investment |
1,863,738,614.60 |
| Investment Properties |
-- |
| Fixed Assetes |
2,112,762,659.90 |
| Under-construction Projects |
137,608,483.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,069,361,203.01 |
| R&D expenses |
20,095,764.13 |
| Goodwill |
168,306,786.43 |
| Long-Term Deferred and Prepaid Expenses |
20,960,377.12 |
| Deferred Income Tax Assets |
37,277,290.69 |
| Other Non-Current Assets |
198,198,452.08 |
| Sub-Total of Non-Current Assets |
5,711,583,371.07 |
| Total Assets |
8,679,082,010.79 |
| Short-Term Loans |
1,474,946,257.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
897,980,000.00 |
| Accounts Payable |
329,581,200.88 |
| Accounts Received In Advance |
6,501,223.91 |
| Employee Compensation Payable |
17,604,080.19 |
| Taxes Payable |
77,239,411.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
116,037,027.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
307,259,817.03 |
| Other Current Liabilities |
1,383,162.37 |
| Sub-Total of Current Liabilities |
3,240,202,378.67 |
| Long-term Loans |
1,108,744,877.92 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
666,723,773.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
153,953,120.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,080,311,676.18 |
| Total Liabilities |
5,320,514,054.85 |
| Paid-In Capital(Or Share Stock) |
1,656,158,416.00 |
| Capital Surplus |
1,402,943,737.07 |
| Surplus Reserve |
38,216,806.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-219,044,100.79 |
| Minority Stockholder's Interest |
557,162,855.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,801,405,100.66 |
| Owner's Equity（Stockholder's Equity） |
3,358,567,955.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,679,082,010.79 |
